Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 21.28%. Currently, Cytokinetics has a market capitalization of $10.34 billion.
Buying $100 In CYTK: If an investor had bought $100 of CYTK stock 10 years ago, it would be worth $598.84 today based on a price of $74.36 for CYTK at the time of writing.
Cytokinetics’s Performance Over Last 10 Years
Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment